Literature DB >> 30021205

External Validation and Clinical Usefulness of First Trimester Prediction Models for the Risk of Preeclampsia: A Prospective Cohort Study.

Linda J E Meertens1, Hubertina C J Scheepers2, Sander M J van Kuijk3, Robert Aardenburg4, Ivo M A van Dooren5, Josje Langenveld4, Annemieke M van Wijck6, Iris Zwaan7, Marc E A Spaanderman2, Luc J M Smits8.   

Abstract

INTRODUCTION: This study assessed the external validity of all published first trimester prediction models for the risk of preeclampsia (PE) based on routinely collected maternal predictors. Moreover, the potential utility of the best-performing models in clinical practice was evaluated.
MATERIAL AND METHODS: Ten prediction models were systematically selected from the literature. We performed a multicenter prospective cohort study in the Netherlands between July 1, 2013, and December 31, 2015. Eligible pregnant women completed a web-based questionnaire before 16 weeks' gestation. The outcome PE was established using postpartum questionnaires and medical records. Predictive performance of each model was assessed by means of discrimination (c-statistic) and a calibration plot. Clinical usefulness was evaluated by means of decision curve analysis and by calculating the potential impact at different risk thresholds.
RESULTS: The validation cohort contained 2,614 women of whom 76 developed PE (2.9%). Five models showed moderate discriminative performance with c-statistics ranging from 0.73 to 0.77. Adequate calibration was obtained after refitting. The best models were clinically useful over a small range of predicted probabilities. DISCUSSION: Five of the ten included first trimester prediction models for PE showed moderate predictive performance. The best models may provide more benefit compared to risk selection as used in current guidelines.
© 2018 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Clinical usefulness; Decision curve analysis; External validation; First trimester; Prediction model; Preeclampsia; Risk assessment

Year:  2018        PMID: 30021205      PMCID: PMC6604271          DOI: 10.1159/000490385

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  6 in total

1.  Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis.

Authors:  John Allotey; Kym Ie Snell; Melanie Smuk; Richard Hooper; Claire L Chan; Asif Ahmed; Lucy C Chappell; Peter von Dadelszen; Julie Dodds; Marcus Green; Louise Kenny; Asma Khalil; Khalid S Khan; Ben W Mol; Jenny Myers; Lucilla Poston; Basky Thilaganathan; Anne C Staff; Gordon Cs Smith; Wessel Ganzevoort; Hannele Laivuori; Anthony O Odibo; Javier A Ramírez; John Kingdom; George Daskalakis; Diane Farrar; Ahmet A Baschat; Paul T Seed; Federico Prefumo; Fabricio da Silva Costa; Henk Groen; Francois Audibert; Jacques Masse; Ragnhild B Skråstad; Kjell Å Salvesen; Camilla Haavaldsen; Chie Nagata; Alice R Rumbold; Seppo Heinonen; Lisa M Askie; Luc Jm Smits; Christina A Vinter; Per M Magnus; Kajantie Eero; Pia M Villa; Anne K Jenum; Louise B Andersen; Jane E Norman; Akihide Ohkuchi; Anne Eskild; Sohinee Bhattacharya; Fionnuala M McAuliffe; Alberto Galindo; Ignacio Herraiz; Lionel Carbillon; Kerstin Klipstein-Grobusch; SeonAe Yeo; Helena J Teede; Joyce L Browne; Karel Gm Moons; Richard D Riley; Shakila Thangaratinam
Journal:  Health Technol Assess       Date:  2020-12       Impact factor: 4.014

2.  Clinical risk assessment in early pregnancy for preeclampsia in nulliparous women: A population based cohort study.

Authors:  Anna Sandström; Jonathan M Snowden; Jonas Höijer; Matteo Bottai; Anna-Karin Wikström
Journal:  PLoS One       Date:  2019-11-27       Impact factor: 3.240

3.  External validation of prognostic models predicting pre-eclampsia: individual participant data meta-analysis.

Authors:  Kym I E Snell; John Allotey; Melanie Smuk; Richard Hooper; Claire Chan; Asif Ahmed; Lucy C Chappell; Peter Von Dadelszen; Marcus Green; Louise Kenny; Asma Khalil; Khalid S Khan; Ben W Mol; Jenny Myers; Lucilla Poston; Basky Thilaganathan; Anne C Staff; Gordon C S Smith; Wessel Ganzevoort; Hannele Laivuori; Anthony O Odibo; Javier Arenas Ramírez; John Kingdom; George Daskalakis; Diane Farrar; Ahmet A Baschat; Paul T Seed; Federico Prefumo; Fabricio da Silva Costa; Henk Groen; Francois Audibert; Jacques Masse; Ragnhild B Skråstad; Kjell Å Salvesen; Camilla Haavaldsen; Chie Nagata; Alice R Rumbold; Seppo Heinonen; Lisa M Askie; Luc J M Smits; Christina A Vinter; Per Magnus; Kajantie Eero; Pia M Villa; Anne K Jenum; Louise B Andersen; Jane E Norman; Akihide Ohkuchi; Anne Eskild; Sohinee Bhattacharya; Fionnuala M McAuliffe; Alberto Galindo; Ignacio Herraiz; Lionel Carbillon; Kerstin Klipstein-Grobusch; Seon Ae Yeo; Joyce L Browne; Karel G M Moons; Richard D Riley; Shakila Thangaratinam
Journal:  BMC Med       Date:  2020-11-02       Impact factor: 8.775

4.  Prediction of preeclampsia risk in first time pregnant women: Metabolite biomarkers for a clinical test.

Authors:  Louise C Kenny; Grégoire Thomas; Lucilla Poston; Jenny E Myers; Nigel A B Simpson; Fergus P McCarthy; Leslie W Brown; Alison E Bond; Robin Tuytten; Philip N Baker
Journal:  PLoS One       Date:  2020-12-28       Impact factor: 3.240

5.  The Tommy's Clinical Decision Tool, a device for reducing the clinical impact of placental dysfunction and preterm birth: protocol for a mixed-methods early implementation evaluation study.

Authors:  Jenny Carter; Dilly Anumba; Lia Brigante; Christy Burden; Tim Draycott; Siobhán Gillespie; Birte Harlev-Lam; Andrew Judge; Erik Lenguerrand; Elaine Sheehan; Basky Thilaganathan; Hannah Wilson; Cathy Winter; Maria Viner; Jane Sandall
Journal:  BMC Pregnancy Childbirth       Date:  2022-08-15       Impact factor: 3.105

6.  Implementing a Preeclampsia Prediction Model in Obstetrics: Cutoff Determination and Health Care Professionals' Adherence.

Authors:  Pim van Montfort; Luc J M Smits; Ivo M A van Dooren; Stéphanie M P Lemmens; Maartje Zelis; Iris M Zwaan; Marc E A Spaanderman; Hubertina C J Scheepers
Journal:  Med Decis Making       Date:  2019-12-02       Impact factor: 2.583

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.